Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000344316

Medchemexpress LLC Opiranserin hydrochloride | 1440796-75-7 | 99.6% | 430.97 | 1 ML
SDP

Catalog No. 5000344316
Encompass_Preferred

Opiranserin (VVZ-149) hydrochloride is a non-opioid and non-NSAID analgesic candidate. It acts as a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A). It also shows antagonistic activity on rP2X3. Opiranserin hydrochloride is being developed as an injectable agent for the treatment of postoperative pain.

  • Is a non-opioid and non-NSAID analgesic candidate.
  • Acts as a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A).
  • Exhibits antagonistic activity on rP2X3.
  • Is being developed as an injectable agent for the treatment of postoperative pain.

Catalog No. 50-003-44316 Supplier Medchemexpress LLC Supplier No. HY109067A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Opiranserin (VVZ-149) hydrochloride is a non-opioid and non-NSAID analgesic candidate. It acts as a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A). It also shows antagonistic activity on rP2X3. Opiranserin hydrochloride is being developed as an injectable agent for the treatment of postoperative pain.

  • Is a non-opioid and non-NSAID analgesic candidate.
  • Acts as a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A).
  • Exhibits antagonistic activity on rP2X3.
  • Is being developed as an injectable agent for the treatment of postoperative pain.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.